United States Healthcare Equipment & Supplies

OraSure Technologies Inc (OSUR)

Track

Track

OraSure Technologies Inc. has seen no insider trading activity within the last three months. The most recent transactions occurred in May 2026, involving multiple share purchases by Steven Kyle Boyd. Prior to this period, executives and board members engaged in various planned acquisitions and sales throughout early 2026 and late 2025.
Ticker: OSUR Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for OraSure Technologies Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.5
Boyd Steven Kyle Non-Executive Director
Transaction date
Purchase
Price
245.44
Quantity 16,897 +33.5%
Value US$4,341,840
3.5
Boyd Steven Kyle Non-Executive Director
Transaction date
Purchase
Price
448.16
Quantity 972 -9.4%
Value US$3,733,261
3.5
Boyd Steven Kyle Non-Executive Director
Transaction date
Purchase
Price
440.69
Quantity 95,557 +22.3%
Value US$137,610
1.8
EGLINTON MANNER CARRIE President & CEO Executive Director
Transaction date
Planned purchase
Price
2.93
Quantity 32,300 +1.5%
Value US$94,597
3.3
McGrath Kenneth J Chief Financial Officer Officer
Transaction date
Planned purchase
Price
2.93
Quantity 32,300 +5.8%
Value US$94,600
3.3
McGrath Kenneth J Chief Financial Officer Officer
Transaction date
Planned purchase
Price
3.00
Quantity 22,021 +4.1%
Value US$66,030
1.8
EGLINTON MANNER CARRIE President & CEO Executive Director
Transaction date
Planned purchase
Price
3.00
Quantity 22,022 +1.0%
Value US$66,033
2.2
Mara Aspinall Board
Transaction date
Proposed sale
Price
2.51
Quantity 89,716
Value US$225,000
2.8
Gagliano Nancy J Non-Executive Director
Transaction date
Purchase
Price
2.37
Quantity 2,100 +1.3%
Value US$4,982
1.8
EGLINTON MANNER CARRIE President & CEO Executive Director
Transaction date
Purchase
Price
3.49
Quantity 28,670 +2.3%
Value US$100,027
2.8
Gagliano Nancy J Non-Executive Director
Transaction date
Purchase
Price
3.08
Quantity 12,750 +16.2%
Value US$39,270
1.8
EGLINTON MANNER CARRIE President & CEO Executive Director
Transaction date
Purchase
Price
3.15
Quantity 78,625 +6.7%
Value US$247,378
3.3
McGrath Kenneth J Chief Financial Officer Officer
Transaction date
Purchase
Price
3.15
Quantity 64,000 +20.8%
Value US$201,683
3.5
Kenny John P. Non-Executive Director
Transaction date
Purchase
Price
3.17
Quantity 47,659 +204.9%
Value US$151,217
1.7
Marmora Lelio Non-Executive Director
Transaction date
Purchase
Price
3.06
Quantity 7,000 +11.5%
Value US$21,420
Weber Kathleen Gallagher Chief Product Officer Officer
Transaction date
Planned sale
Price
8.05
Quantity 24,129 -8.7%
Value US$194,219
Weber Kathleen Gallagher Officer Officer
Transaction date
Proposed sale
Price
8.05
Quantity 24,129
Value US$194,220
1.7
Anthony Michele Marie SVP Finance & CAO Officer
Transaction date
Sale
Price
6.50
Quantity 1,758 -2.0%
Value US$11,427
1.7
Anthony Michele Marie Officer Officer
Transaction date
Proposed sale
Price
6.50
Quantity 1,758
Value US$11,427
3.3
McGrath Kenneth J Chief Financial Officer Officer
Transaction date
Purchase
Price
4.93
Quantity 100,000 +53.9%
Value US$492,810
2.3
LANCASTER RONNY B Non-Executive Director
Transaction date
Purchase
Price
4.00
Quantity 50,000 +91.3%
Value US$200,000
2.2
Aspinall Mara G. Non-Executive Director
Transaction date
Purchase
Price
4.19
Quantity 6,000 +8.4%
Value US$25,138
2.8
Gagliano Nancy J Non-Executive Director
Transaction date
Purchase
Price
4.39
Quantity 2,200 +5.5%
Value US$9,658
3.6
Celano Michael Non-Executive Director
Transaction date
Purchase
Price
4.49
Quantity 12,000 +12.0%
Value US$53,916
Weber Kathleen Gallagher EVP & BU Lead - Molecular Officer
Transaction date
Planned sale
Price
11.76
Quantity 10,000 -9.4%
Value US$117,600
3.4
TANG STEPHEN S PHD President and CEO
Transaction date
Purchase
Price
8.56
Quantity 1,000 +0.8%
Value US$8,560
0.9
JERRETT JACK E SVP & General Counsel
Transaction date
Purchase
Price
8.55
Quantity 8,687 +10.4%
Value US$74,274
0.9
JERRETT JACK E SVP & General Counsel
Transaction date
Purchase
Price
8.54
Quantity 1,313 +1.6%
Value US$11,213
3.3
Cuca Roberto CFO
Transaction date
Purchase
Price
9.00
Quantity 407 +0.9%
Value US$3,663
3.3
Cuca Roberto CFO
Transaction date
Purchase
Price
9.03
Quantity 700 +1.5%
Value US$6,321
3.3
Cuca Roberto CFO
Transaction date
Purchase
Price
9.02
Quantity 1,200 +2.7%
Value US$10,824
3.3
Cuca Roberto CFO
Transaction date
Purchase
Price
9.01
Quantity 1,300 +3.0%
Value US$11,713
3.3
Cuca Roberto CFO
Transaction date
Purchase
Price
9.04
Quantity 6,393 +17.0%
Value US$57,793
3.4
TANG STEPHEN S PHD President and CEO
Transaction date
Sale
Price
11.10
Quantity 16,667 -12.3%
Value US$185,015
Patrick Charles W Non-Executive Director
Transaction date
Sale
Price
16.29
Quantity 8,000 -12.8%
Value US$130,320
SMITH BRIAN EVP & BU Lead - Molecular Officer
Transaction date
Sale
Price
18.00
Quantity 10,000 -35.6%
Value US$180,010
TANG STEPHEN S PHD Non-Executive Director
Transaction date
Sale
Price
17.97
Quantity 23,333 -39.1%
Value US$419,247
SMITH BRIAN EVP & BU Lead - Molecular Officer
Transaction date
Sale
Price
17.95
Quantity 10,000 -35.6%
Value US$179,450
Aspinall Mara G.
Transaction date
Purchase
Price
14.23
Quantity 5,000 +inf%
Value US$71,164
Michels Douglas A President & CEO Executive Director
Transaction date
Planned sale
Price
23.00
Quantity 22,923 -3.1%
Value US$527,229
Michels Douglas A President & CEO Executive Director
Transaction date
Planned sale
Price
22.55
Quantity 25,000 -3.3%
Value US$563,712
SMITH BRIAN See Remarks
Transaction date
Sale
Price
20.40
Quantity 100 -0.4%
Value US$2,040
SMITH BRIAN See Remarks
Transaction date
Sale
Price
20.47
Quantity 9,012 -27.7%
Value US$184,476
Patrick Charles W
Transaction date
Sale
Price
20.11
Quantity 1,000 -1.9%
Value US$20,110
SMITH BRIAN SEE REMARKS
Transaction date
Sale
Price
21.12
Quantity 1,075 -4.4%
Value US$22,704
SMITH BRIAN SEE REMARKS
Transaction date
Sale
Price
21.08
Quantity 2,000 -7.5%
Value US$42,160
Zezzo II Anthony EVP - Infectious Diseases
Transaction date
Sale
Price
21.26
Quantity 72,916 -33.4%
Value US$1,550,296
JERRETT JACK E SVP & General Counsel
Transaction date
Sale
Price
21.03
Quantity 9,623 -16.4%
Value US$202,366
JERRETT JACK E SVP & General Counsel
Transaction date
Sale
Price
20.73
Quantity 63,840 -52.0%
Value US$1,323,282
SPAIR RONALD H COO & CFO Executive Director
Transaction date
Sale
Price
21.29
Quantity 176,197 -61.8%
Value US$3,751,675
KUNA MARK L SVP & Controller
Transaction date
Sale
Price
21.32
Quantity 15,000 -23.6%
Value US$319,800
SPAIR RONALD H COO & CFO Executive Director
Transaction date
Sale
Price
20.32
Quantity 333,915 -75.4%
Value US$6,785,754
KUNA MARK L SVP & Controller
Transaction date
Sale
Price
20.22
Quantity 46,959 -42.5%
Value US$949,567
Michels Douglas A President & CEO Executive Director
Transaction date
Planned sale
Price
16.28
Quantity 89,541 -10.4%
Value US$1,457,817
Michels Douglas A President & CEO Executive Director
Transaction date
Planned sale
Price
16.67
Quantity 75,000 -8.0%
Value US$1,250,475
Michels Douglas A President & CEO Executive Director
Transaction date
Planned sale
Price
17.13
Quantity 125,954 -11.9%
Value US$2,157,970
SPAIR RONALD H COO & CFO Executive Director
Transaction date
Sale
Price
15.06
Quantity 50,000 -31.4%
Value US$752,890
LANCASTER RONNY B Non-Executive Director
Transaction date
Sale
Price
15.07
Quantity 15,000 -70.4%
Value US$225,975
Patrick Charles W Non-Executive Director
Transaction date
Sale
Price
15.15
Quantity 6,666 -11.3%
Value US$100,990
LANCASTER RONNY B Non-Executive Director
Transaction date
Sale
Price
14.73
Quantity 74,684 -92.2%
Value US$1,100,394
Zezzo II Anthony EVP, Marketing and Sales Officer
Transaction date
Sale
Price
14.70
Quantity 115,000 -44.2%
Value US$1,690,845
Michels Douglas A President & CEO Executive Director
Transaction date
Sale
Price
15.01
Quantity 209,800 -21.5%
Value US$3,149,098
Michels Douglas A President & CEO Executive Director
Transaction date
Sale
Price
15.09
Quantity 167,916 -17.9%
Value US$2,533,852
Michels Douglas A President & CEO Executive Director
Transaction date
Sale
Price
15.09
Quantity 79,738 -9.4%
Value US$1,203,246
SPAIR RONALD H COO & CFO Executive Director
Transaction date
Sale
Price
15.03
Quantity 6,500 -5.6%
Value US$97,695
KUNA MARK L SVP & Controller Officer
Transaction date
Sale
Price
15.00
Quantity 1,698 -2.6%
Value US$25,470
KUNA MARK L SVP & Controller Officer
Transaction date
Sale
Price
15.00
Quantity 5,302 -7.7%
Value US$79,530
Michels Douglas A President & CEO Executive Director
Transaction date
Sale
Price
15.06
Quantity 113,562 -12.9%
Value US$1,710,244
SPAIR RONALD H COO & CFO Executive Director
Transaction date
Sale
Price
15.00
Quantity 66,064 -37.7%
Value US$990,960
PRINGLE ROGER L Non-Executive Director
Transaction date
Sale
Price
14.93
Quantity 140,552 -64.8%
Value US$2,098,863
Patrick Charles W Non-Executive Director
Transaction date
Sale
Price
14.96
Quantity 745 -1.3%
Value US$11,145
Patrick Charles W Non-Executive Director
Transaction date
Sale
Price
14.96
Quantity 9,255 -100.0%
Value US$138,455
Celano Michael Non-Executive Director
Transaction date
Sale
Price
14.95
Quantity 44,962 -54.1%
Value US$672,182
KUNA MARK L SVP & Controller Officer
Transaction date
Sale
Price
15.13
Quantity 29,413 -31.7%
Value US$445,019
TANG STEPHEN S PHD Non-Executive Director
Transaction date
Planned sale
Price
12.00
Quantity 220 -0.7%
Value US$2,640
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-14 2026-05-14 B Purchase
3.5
Boyd Steven Kyle
Non-Executive Director
16,897 +33.5%
245.44
US$4,341,840 		16,897 +33.5% 245.44 US$4,341,840
2026-05-14 2026-05-13 B Purchase
3.5
Boyd Steven Kyle
Non-Executive Director
972 -9.4%
448.16
US$3,733,261 		972 -9.4% 448.16 US$3,733,261
2026-05-14 2026-05-12 B Purchase
3.5
Boyd Steven Kyle
Non-Executive Director
95,557 +22.3%
440.69
US$137,610 		95,557 +22.3% 440.69 US$137,610
2026-03-23 2026-03-20 PP Planned purchase
1.8
EGLINTON MANNER CARRIE

President & CEO

Executive Director
32,300 +1.5%
2.93
US$94,597 		32,300 +1.5% 2.93 US$94,597
2026-03-23 2026-03-20 PP Planned purchase
3.3
McGrath Kenneth J

Chief Financial Officer

Officer
32,300 +5.8%
2.93
US$94,600 		32,300 +5.8% 2.93 US$94,600
2026-03-16 2026-03-13 PP Planned purchase
3.3
McGrath Kenneth J

Chief Financial Officer

Officer
22,021 +4.1%
3.00
US$66,030 		22,021 +4.1% 3.00 US$66,030
2026-03-16 2026-03-13 PP Planned purchase
1.8
EGLINTON MANNER CARRIE

President & CEO

Executive Director
22,022 +1.0%
3.00
US$66,033 		22,022 +1.0% 3.00 US$66,033
2025-12-04 2025-12-04 PrS Proposed sale
2.2
Mara Aspinall

Board
89,716
2.51
US$225,000 		89,716 2.51 US$225,000
2025-12-02 2025-11-28 B Purchase
2.8
Gagliano Nancy J
Non-Executive Director
2,100 +1.3%
2.37
US$4,982 		2,100 +1.3% 2.37 US$4,982
2025-03-03 2025-02-28 B Purchase
1.8
EGLINTON MANNER CARRIE

President & CEO

Executive Director
28,670 +2.3%
3.49
US$100,027 		28,670 +2.3% 3.49 US$100,027
2025-03-03 2025-02-27 B Purchase
2.8
Gagliano Nancy J
Non-Executive Director
12,750 +16.2%
3.08
US$39,270 		12,750 +16.2% 3.08 US$39,270
2025-02-27 2025-02-27 B Purchase
1.8
EGLINTON MANNER CARRIE

President & CEO

Executive Director
78,625 +6.7%
3.15
US$247,378 		78,625 +6.7% 3.15 US$247,378
2025-02-27 2025-02-27 B Purchase
3.3
McGrath Kenneth J

Chief Financial Officer

Officer
64,000 +20.8%
3.15
US$201,683 		64,000 +20.8% 3.15 US$201,683
2025-02-27 2025-02-27 B Purchase
3.5
Kenny John P.
Non-Executive Director
47,659 +204.9%
3.17
US$151,217 		47,659 +204.9% 3.17 US$151,217
2025-02-27 2025-02-27 B Purchase
1.7
Marmora Lelio
Non-Executive Director
7,000 +11.5%
3.06
US$21,420 		7,000 +11.5% 3.06 US$21,420
2023-12-21 2023-12-19 PlS Planned sale
Weber Kathleen Gallagher

Chief Product Officer

Officer
24,129 -8.7%
8.05
US$194,219 		24,129 -8.7% 8.05 US$194,219
2023-12-19 2023-12-19 PrS Proposed sale
Weber Kathleen Gallagher

Officer

Officer
24,129
8.05
US$194,220 		24,129 8.05 US$194,220
2023-08-17 2023-08-15 S Sale
1.7
Anthony Michele Marie

SVP Finance & CAO

Officer
1,758 -2.0%
6.50
US$11,427 		1,758 -2.0% 6.50 US$11,427
2023-08-15 2023-08-15 PrS Proposed sale
1.7
Anthony Michele Marie

Officer

Officer
1,758
6.50
US$11,427 		1,758 6.50 US$11,427
2023-05-31 2023-05-30 B Purchase
3.3
McGrath Kenneth J

Chief Financial Officer

Officer
100,000 +53.9%
4.93
US$492,810 		100,000 +53.9% 4.93 US$492,810
2022-08-29 2022-08-26 B Purchase
2.3
LANCASTER RONNY B
Non-Executive Director
50,000 +91.3%
4.00
US$200,000 		50,000 +91.3% 4.00 US$200,000
2022-08-31 2022-08-25 B Purchase
2.2
Aspinall Mara G.
Non-Executive Director
6,000 +8.4%
4.19
US$25,138 		6,000 +8.4% 4.19 US$25,138
2022-08-22 2022-08-17 B Purchase
2.8
Gagliano Nancy J
Non-Executive Director
2,200 +5.5%
4.39
US$9,658 		2,200 +5.5% 4.39 US$9,658
2022-08-16 2022-08-12 B Purchase
3.6
Celano Michael
Non-Executive Director
12,000 +12.0%
4.49
US$53,916 		12,000 +12.0% 4.49 US$53,916
2021-01-04 2020-12-23 PlS Planned sale
Weber Kathleen Gallagher

EVP & BU Lead - Molecular

Officer
10,000 -9.4%
11.76
US$117,600 		10,000 -9.4% 11.76 US$117,600
2019-05-14 2019-05-14 B Purchase
3.4
TANG STEPHEN S PHD

President and CEO
1,000 +0.8%
8.56
US$8,560 		1,000 +0.8% 8.56 US$8,560
2019-05-14 2019-05-13 B Purchase
0.9
JERRETT JACK E

SVP & General Counsel
8,687 +10.4%
8.55
US$74,274 		8,687 +10.4% 8.55 US$74,274
2019-05-14 2019-05-13 B Purchase
0.9
JERRETT JACK E

SVP & General Counsel
1,313 +1.6%
8.54
US$11,213 		1,313 +1.6% 8.54 US$11,213
2019-05-14 2019-05-10 B Purchase
3.3
Cuca Roberto

CFO
407 +0.9%
9.00
US$3,663 		407 +0.9% 9.00 US$3,663
2019-05-14 2019-05-10 B Purchase
3.3
Cuca Roberto

CFO
700 +1.5%
9.03
US$6,321 		700 +1.5% 9.03 US$6,321
2019-05-14 2019-05-10 B Purchase
3.3
Cuca Roberto

CFO
1,200 +2.7%
9.02
US$10,824 		1,200 +2.7% 9.02 US$10,824
2019-05-14 2019-05-10 B Purchase
3.3
Cuca Roberto

CFO
1,300 +3.0%
9.01
US$11,713 		1,300 +3.0% 9.01 US$11,713
2019-05-14 2019-05-10 B Purchase
3.3
Cuca Roberto

CFO
6,393 +17.0%
9.04
US$57,793 		6,393 +17.0% 9.04 US$57,793
2019-04-03 2019-04-01 S Sale
3.4
TANG STEPHEN S PHD

President and CEO
16,667 -12.3%
11.10
US$185,015 		16,667 -12.3% 11.10 US$185,015
2018-08-29 2018-08-27 S Sale Patrick Charles W Non-Executive Director
8,000 -12.8%
16.29
US$130,320 		8,000 -12.8% 16.29 US$130,320
2018-02-20 2018-02-16 S Sale SMITH BRIAN

EVP & BU Lead - Molecular

Officer
10,000 -35.6%
18.00
US$180,010 		10,000 -35.6% 18.00 US$180,010
2018-02-20 2018-02-15 S Sale TANG STEPHEN S PHD Non-Executive Director
23,333 -39.1%
17.97
US$419,247 		23,333 -39.1% 17.97 US$419,247
2018-02-20 2018-02-15 S Sale SMITH BRIAN

EVP & BU Lead - Molecular

Officer
10,000 -35.6%
17.95
US$179,450 		10,000 -35.6% 17.95 US$179,450
2017-11-09 2017-11-07 B Purchase Aspinall Mara G.
5,000 +inf%
14.23
US$71,164 		5,000 +inf% 14.23 US$71,164
2017-10-06 2017-10-04 PlS Planned sale Michels Douglas A

President & CEO

Executive Director
22,923 -3.1%
23.00
US$527,229 		22,923 -3.1% 23.00 US$527,229
2017-10-03 2017-09-29 PlS Planned sale Michels Douglas A

President & CEO

Executive Director
25,000 -3.3%
22.55
US$563,712 		25,000 -3.3% 22.55 US$563,712
2017-09-05 2017-08-31 S Sale SMITH BRIAN

See Remarks
100 -0.4%
20.40
US$2,040 		100 -0.4% 20.40 US$2,040
2017-09-05 2017-08-31 S Sale SMITH BRIAN

See Remarks
9,012 -27.7%
20.47
US$184,476 		9,012 -27.7% 20.47 US$184,476
2017-08-31 2017-08-30 S Sale Patrick Charles W
1,000 -1.9%
20.11
US$20,110 		1,000 -1.9% 20.11 US$20,110
2017-08-24 2017-08-22 S Sale SMITH BRIAN

SEE REMARKS
1,075 -4.4%
21.12
US$22,704 		1,075 -4.4% 21.12 US$22,704
2017-08-24 2017-08-22 S Sale SMITH BRIAN

SEE REMARKS
2,000 -7.5%
21.08
US$42,160 		2,000 -7.5% 21.08 US$42,160
2017-08-09 2017-08-07 S Sale Zezzo II Anthony

EVP - Infectious Diseases
72,916 -33.4%
21.26
US$1,550,296 		72,916 -33.4% 21.26 US$1,550,296
2017-08-08 2017-08-07 S Sale JERRETT JACK E

SVP & General Counsel
9,623 -16.4%
21.03
US$202,366 		9,623 -16.4% 21.03 US$202,366
2017-08-08 2017-08-07 S Sale JERRETT JACK E

SVP & General Counsel
63,840 -52.0%
20.73
US$1,323,282 		63,840 -52.0% 20.73 US$1,323,282
2017-08-08 2017-08-07 S Sale SPAIR RONALD H

COO & CFO

Executive Director
176,197 -61.8%
21.29
US$3,751,675 		176,197 -61.8% 21.29 US$3,751,675
2017-08-08 2017-08-07 S Sale KUNA MARK L

SVP & Controller
15,000 -23.6%
21.32
US$319,800 		15,000 -23.6% 21.32 US$319,800
2017-08-08 2017-08-04 S Sale SPAIR RONALD H

COO & CFO

Executive Director
333,915 -75.4%
20.32
US$6,785,754 		333,915 -75.4% 20.32 US$6,785,754
2017-08-08 2017-08-04 S Sale KUNA MARK L

SVP & Controller
46,959 -42.5%
20.22
US$949,567 		46,959 -42.5% 20.22 US$949,567
2017-06-29 2017-06-27 PlS Planned sale Michels Douglas A

President & CEO

Executive Director
89,541 -10.4%
16.28
US$1,457,817 		89,541 -10.4% 16.28 US$1,457,817
2017-06-29 2017-06-27 PlS Planned sale Michels Douglas A

President & CEO

Executive Director
75,000 -8.0%
16.67
US$1,250,475 		75,000 -8.0% 16.67 US$1,250,475
2017-06-29 2017-06-27 PlS Planned sale Michels Douglas A

President & CEO

Executive Director
125,954 -11.9%
17.13
US$2,157,970 		125,954 -11.9% 17.13 US$2,157,970
2017-06-02 2017-05-31 S Sale SPAIR RONALD H

COO & CFO

Executive Director
50,000 -31.4%
15.06
US$752,890 		50,000 -31.4% 15.06 US$752,890
2017-05-30 2017-05-30 S Sale LANCASTER RONNY B Non-Executive Director
15,000 -70.4%
15.07
US$225,975 		15,000 -70.4% 15.07 US$225,975
2017-05-30 2017-05-30 S Sale Patrick Charles W Non-Executive Director
6,666 -11.3%
15.15
US$100,990 		6,666 -11.3% 15.15 US$100,990
2017-05-30 2017-05-26 S Sale LANCASTER RONNY B Non-Executive Director
74,684 -92.2%
14.73
US$1,100,394 		74,684 -92.2% 14.73 US$1,100,394
2017-05-11 2017-05-10 S Sale Zezzo II Anthony

EVP, Marketing and Sales

Officer
115,000 -44.2%
14.70
US$1,690,845 		115,000 -44.2% 14.70 US$1,690,845
2017-05-11 2017-05-09 S Sale Michels Douglas A

President & CEO

Executive Director
209,800 -21.5%
15.01
US$3,149,098 		209,800 -21.5% 15.01 US$3,149,098
2017-05-09 2017-05-08 S Sale Michels Douglas A

President & CEO

Executive Director
167,916 -17.9%
15.09
US$2,533,852 		167,916 -17.9% 15.09 US$2,533,852
2017-05-09 2017-05-08 S Sale Michels Douglas A

President & CEO

Executive Director
79,738 -9.4%
15.09
US$1,203,246 		79,738 -9.4% 15.09 US$1,203,246
2017-05-09 2017-05-08 S Sale SPAIR RONALD H

COO & CFO

Executive Director
6,500 -5.6%
15.03
US$97,695 		6,500 -5.6% 15.03 US$97,695
2017-05-09 2017-05-08 S Sale KUNA MARK L

SVP & Controller

Officer
1,698 -2.6%
15.00
US$25,470 		1,698 -2.6% 15.00 US$25,470
2017-05-09 2017-05-08 S Sale KUNA MARK L

SVP & Controller

Officer
5,302 -7.7%
15.00
US$79,530 		5,302 -7.7% 15.00 US$79,530
2017-05-09 2017-05-05 S Sale Michels Douglas A

President & CEO

Executive Director
113,562 -12.9%
15.06
US$1,710,244 		113,562 -12.9% 15.06 US$1,710,244
2017-05-09 2017-05-05 S Sale SPAIR RONALD H

COO & CFO

Executive Director
66,064 -37.7%
15.00
US$990,960 		66,064 -37.7% 15.00 US$990,960
2017-05-09 2017-05-05 S Sale PRINGLE ROGER L Non-Executive Director
140,552 -64.8%
14.93
US$2,098,863 		140,552 -64.8% 14.93 US$2,098,863
2017-05-09 2017-05-05 S Sale Patrick Charles W Non-Executive Director
745 -1.3%
14.96
US$11,145 		745 -1.3% 14.96 US$11,145
2017-05-09 2017-05-05 S Sale Patrick Charles W Non-Executive Director
9,255 -100.0%
14.96
US$138,455 		9,255 -100.0% 14.96 US$138,455
2017-05-09 2017-05-05 S Sale Celano Michael Non-Executive Director
44,962 -54.1%
14.95
US$672,182 		44,962 -54.1% 14.95 US$672,182
2017-05-09 2017-05-05 S Sale KUNA MARK L

SVP & Controller

Officer
29,413 -31.7%
15.13
US$445,019 		29,413 -31.7% 15.13 US$445,019
2017-03-23 2017-03-21 PlS Planned sale TANG STEPHEN S PHD Non-Executive Director
220 -0.7%
12.00
US$2,640 		220 -0.7% 12.00 US$2,640
Explore more

More insider trading research around OraSure Technologies Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America